Galaxy S4 reaches 10 million in sales in less than 30 days

South Korea based Samsung Electronics announced that global sales for its newest smartphone Galaxy S4 had reached 10 million in less than a month after its global launch date.

The latest in Samsung’s stable of smartphones has successfully out done its predecessors for its first month of sales. The Galaxy SIII reached 10 million in sales in 2012, 55 days after it was launched. The Galaxy SII was able to reach the 10 million sales mark in just over five months and the Galaxy S needed seven months to reach the 10 million mark in sales, said officials from the company.

The Galaxy is now available in over 110 countries worldwide and eventually, said company officials, will be available in a total of 155 countries.

The S4 has 5-inch full HD display that contains 441 pixels per inch and has a front and back camera that users can use simultaneously.

Samsung announced that more colors would be offered for the Galaxy S4. At this time, purchasers can buy the Black Forest or White Mist models. However, in the summer colors available will include Blue Arctic as well as Red Aurora. Following that, the company will release a Purple Mirage and Brown Autumn.

Samsung during the first three months of 2013 had a smartphone market share of 31% compared to the 18.2% held by Apple.

Samsung has also earned 95% of the entire smartphone profits of Androids during the same three months. Globally profits from smartphones running the Android platform reached close to $5 billion in the first quarter of 2013 and represented more than 43% of the entire market for smartphone operating profits.

Latest News

Somewhat Positive Media Coverage Somewhat Unlikely to Impact Gemphire Therapeutics  Stock Price
Somewhat Positive Media Coverage Somewhat Unlikely to Impact Gemphire Therapeutics Stock Price
Aviat Networks  Given Daily Media Impact Rating of 0.09
Aviat Networks Given Daily Media Impact Rating of 0.09
Papa Murphy’s  Getting Somewhat Positive News Coverage, Report Shows
Papa Murphy’s Getting Somewhat Positive News Coverage, Report Shows
EXFO  Given Average Recommendation of “Hold” by Brokerages
EXFO Given Average Recommendation of “Hold” by Brokerages
Brokerages Set ANI Pharmaceuticals Inc Common Stock  Price Target at $79.00
Brokerages Set ANI Pharmaceuticals Inc Common Stock Price Target at $79.00
MediBloc [QRC20] Price Tops $0.0061 on Top Exchanges
MediBloc [QRC20] Price Tops $0.0061 on Top Exchanges


© 2006-2018 Ticker Report. Google+.